{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:10:27Z","timestamp":1791216627026,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1842,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1365-2982.2010.01587.x","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T07:34:44Z","timestamp":1281944084000},"page":"30-e2","source":"Crossref","is-referenced-by-count":53,"title":["The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients"],"prefix":"10.1111","volume":"23","author":[{"given":"T. K.","family":"Klooker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E. M.","family":"Leliefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Van Den Wijngaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. E. E.","family":"Boeckxstaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2001.21908","article-title":"Management of the irritable bowel syndrome","volume":"120","author":"Camilleri","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1053\/gast.2002.33601","article-title":"Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds","volume":"122","author":"Bouin","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0016-5085(94)90086-8","article-title":"Basic and clinical aspects of visceral hyperalgesia","volume":"107","author":"Mayer","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2036.2007.03398.x","article-title":"Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome","volume":"4","author":"Klooker","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2036.2005.02524.x","article-title":"Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome","volume":"2","author":"Kuiken","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1053\/j.gastro.2007.07.024","article-title":"Altered rectal perception in irritable bowel syndrome is associated with symptom severity","volume":"133","author":"Posserud","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cgh.2007.12.005","article-title":"Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome","volume":"6","author":"Van D","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(95)90267-8","article-title":"Altered rectal perception is a biological marker of patients with irritable bowel syndrome","volume":"109","author":"Mertz","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0016-5085(97)70219-1","article-title":"Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome","volume":"112","author":"Munakata","year":"1997","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1111\/j.1365-2982.2010.01587.x-BIB10|cit10","first-page":"47","article-title":"Endocannabinoids and the gastrointestinal tract","volume":"3","author":"Massa","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0163-7258(02)00252-8","article-title":"Cannabinoid analgesia","volume":"95","author":"Walker","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/plef.2001.0362","article-title":"Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy","volume":"3","author":"Rice","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1365-2982.2006.00819.x","article-title":"Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats","volume":"18","author":"Sanson","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1254\/jphs.FP0071599","article-title":"Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity","volume":"106","author":"Kikuchi","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm1521","article-title":"Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors","volume":"13","author":"Rousseaux","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"G137","DOI":"10.1152\/ajpgi.00565.2006","article-title":"Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study","volume":"293","author":"Esfandyari","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1476-5381.2008.00010.x","article-title":"Effect of Delta-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans","volume":"156","author":"Beaumont","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","article-title":"The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain","volume":"2","author":"Jaggar","year":"1998","journal-title":"Pain"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3959(99)00045-7","article-title":"Spinal cannabinoids are anti-allodynic in rats with persistent inflammation","volume":"82","author":"Martin","year":"1999","journal-title":"Pain"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0704110","article-title":"The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain","volume":"133","author":"Bridges","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00474-7","article-title":"The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain","volume":"2","author":"Fox","year":"2001","journal-title":"Pain"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(01)00336-0","article-title":"Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms","volume":"93","author":"Johanek","year":"2001","journal-title":"Pain"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0304-3959(02)00401-3","article-title":"Cannabinoid agonists attenuate capsaicin-induced responses in human skin","volume":"102","author":"Rukwied","year":"2003","journal-title":"Pain"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3959(97)00213-3","article-title":"Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors","volume":"75","author":"Richardson","year":"1998","journal-title":"Pain"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1572-0241.1999.01009.x","article-title":"Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome","volume":"94","author":"Lembo","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2036.2004.01774.x","article-title":"Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome","volume":"1","author":"Schwetz","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gut.2008.148791","article-title":"Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects","volume":"57","author":"Izzo","year":"2008","journal-title":"Gut"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-004-1941-4","article-title":"The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats","volume":"177","author":"Bortolato","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20","article-title":"Behavioral effects of cannabinoid agents in animals","volume":"13","author":"Chaperon","year":"1999","journal-title":"Crit Rev Neurobiol"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(25)06864-4","article-title":"Cannabinoid pharmacology","volume":"38","author":"Dewey","year":"1986","journal-title":"Pharmacol Rev"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000050681","article-title":"Role of stress in functional gastrointestinal disorders evidence for stress-induced alterations in gastrointestinal motility and sensitivity","volume":"19","author":"Monnikes","year":"2001","journal-title":"Dig Dis"},{"key":"10.1111\/j.1365-2982.2010.01587.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/gut.2003.017962","article-title":"Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress","volume":"53","author":"Posserud","year":"2004","journal-title":"Gut"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2010.01587.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2982.2010.01587.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:37:33Z","timestamp":1740411453000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2010.01587.x"}},"subtitle":["The effect of \u03949-THC on visceral sensitivity"],"short-title":[],"issued":{"date-parts":[[2010,8,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2010.01587.x","relation":{},"ISSN":["1350-1925"],"issn-type":[{"value":"1350-1925","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,16]]}}}